Zhende Medical(SH:603301) Shang Hai Zheng Quan Bao·2025-09-15 20:02Core Viewpoint - The stock of Zhend Medical Supplies Co., Ltd. experienced an abnormal trading fluctuation, with a cumulative closing price increase exceeding 20% over three consecutive trading days from September 11 to September 15, 2025 [2][4]. Group 1: Stock Trading Abnormality - The stock price deviation was identified as an abnormal trading situation according to the Shanghai Stock Exchange trading rules [2][4]. - The company confirmed that there were no undisclosed significant matters or important information as of the announcement date [2][6]. Group 2: Company Operations - The company reported that its production and operations are normal, with no significant changes in the external operating environment or industry policies [5]. Group 3: Major Transactions - On September 10, 2025, the controlling shareholder, Zhejiang Zhend Holdings Co., Ltd., and its wholly-owned subsidiary signed a share transfer agreement to transfer a total of 13,322,560 shares (5.00% of total share capital) at a price of RMB 26.74 per share [6]. - The total transaction value is approximately RMB 356.25 million [6]. Group 4: Compliance and Risk - The share transfer is subject to compliance review by the Shanghai Stock Exchange and must complete the share transfer registration process, which may involve the release of pledged shares [7]. - The company has not identified any media reports or market rumors that could significantly impact the stock price [8]. - There were no significant stock trading activities by directors, senior management, or controlling shareholders during the abnormal trading period [9].